Disclosure under SEBI Takeover Regulations

April 7, 2026 The Corporate Services Department, Manager - Listing Department Bombay Stock Exchange Limited The National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex Mumbai- 400 001 Bandra (E), Mumbai - 400 051 Scrip Code: 543434 NSE Symbol: SUPRIYA Sub: Disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Dear Sir/Madam, Pursuant to provisions of Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, we the promoter and members of the Promoter Group as mentioned below have not made any encumbrance of shares, directly or indirectly, during the Financial Year ended March 31, 2026. Kindly acknowledge the receipt of the same and take on your record. Thanking you, Yours faithfully, For and on behalf of the Promoter and members of Promoter Group of Supriya Lifescience Limited Satish Waman Wagh Promoter Encl: As above DISCLOSURES UNDER REGULATION 31(4) OF SEBI (SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVERS) REGULATIONS, 2011 Name of the Target Company (TC) Supriya Lifescience Limited Name of the Promoters, members of the Promoter: promoter group Satish Waman Wagh Members of the promoter group: Smita Satish Wagh Saloni Satish Wagh Shivani Satish Wagh Arun Wagh Anjali Sabnis Pornima Mehta Satyajit Vanikar Sameer Vanikar Supriya Medi-Chem Private Limited Lote Industries Testing Laboratory Association Swastik Industries Prime Chemicals Vaibhav Chemicals Supriya Pharmaceuticals Ravi Industries Supriya Aviation For and on behalf of the Promoter and members of Promoter Group of Supriya Lifescience Limited Satish Waman Wagh Promoter The Audit Committee Supriya Lifescience Limited Reg. Office: 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400063.